Skip to main content

Month: December 2020

Victory Square Technologies to Present at the Lytham Partners End of Year 1×1 Conference 

VANCOUVER, British Columbia, Dec. 04, 2020 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) a company that builds and invests in cutting-edge technology that is shaping the 4th Industrial Revolution is pleased to announce it will be participating in the Lytham Partners End of Year 1×1 Conference.  Lytham Partners is one of the country’s leading investor relations firms. Their investor conferences are an ideal platform for bringing public companies and investors together. Lytham Partners End of Year 1×1 Conference will be held on December 7th through 11th, 2020. This event is focused on connecting companies with institutional investors in a virtual 1×1 format with a focus on communicating positioning and strategies for 2021. VST’s Chief Executive Officer,...

Continue reading

Citadel Income Fund Announces Annual Redemption Details

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — Citadel Income Fund (TSX – CTF.UN) (the “Fund”) is pleased to announce that, with respect to the previously announced annual redemption of 1,367,941 units of the Fund, the redemption price per unit is $3.9997.The pro-rata redemption rate will be 13.9% (i.e. for every 1,000 units submitted by a unitholder for redemption, 139 units will be redeemed).For further information, please contact your financial advisor, call Artemis Investment Management’s investor relations line at (416) 934‐7455 or visit our website at www.artemisfunds.ca. 

Continue reading

Energy Income Fund Announces Annual Redemption Details

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — Energy Income Fund (TSX – ENI.UN) (the “Fund”) is pleased to announce that, with respect to the previously announced annual redemption of 352,610 units of the Fund, the redemption price per unit is $1.8179.The pro-rata redemption rate will be 21.7% (i.e. for every 1,000 units submitted by a unitholder for redemption, 217 units will be redeemed).For further information, please contact your financial advisor, call Artemis Investment Management’s investor relations line at (416) 934‐7455 or visit our website at www.artemisfunds.ca.

Continue reading

Ayr Strategies to Begin Trading Immediately on OTC Under New Symbol “AYRWF”

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a vertically-integrated cannabis multi-state operator (MSO), will begin trading effective immediately under a new symbol, “AYRWF.” This change is the result of an administrative issue at FINRA that caused the accidental retirement of the former ticker symbol and temporary suspension of trading on the OTC earlier today. The most effective and immediate remedy to the situation was for the Company to establish a new trading symbol on the OTC Pink Open Market to prevent further delay in trading. As soon as practical, it will return to being quoted on the OTCQX® Best Market. There is no action required by shareholders. The Company’s shares will continue to trade without disruption on the CSE under the ticker, “AYR.A.”  Forward-Looking...

Continue reading

Verizon to speak at UBS Global TMT Conference December 7

BASKING RIDGE, N.J., Dec. 04, 2020 (GLOBE NEWSWIRE) — Hans Vestberg, Chairman and CEO for Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the virtual UBS Global TMT Conference on Monday, December 7, at 10:15 a.m. ET. His remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors/.Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is celebrating its 20th year as one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $131.9 billion in 2019. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’...

Continue reading

REC Silicon – Approval and publication of prospectus

Lysaker, 4 December 2020. Reference is made to the stock exchange announcements by REC Silicon ASA (the “Company”) on 14 October 2020 and 15 October 2020 regarding the successful completion of a private placement raising gross proceeds of approximately NOK 1,000 million (the “Private Placement”).A prospectus for listing of the 92,592,592 new shares in the Company issued in connection with the Private Placement was approved by the Financial Supervisory Authority of Norway on 4 December 2020. The prospectus and a summary of the prospectus will be available at the Company’s website www.recsilicon.com.For further information, please contact:James A. May II, Chief Financial OfficerPhone: +1 509 989 1023Email: james.may@recsilicon.comNils O. KjerstadIR ContactPhone: +47 9135 6659Email: nils.kjerstad@crux.noAbout...

Continue reading

HD Supply Holdings, Inc. Announces Fiscal 2020 Third-Quarter Results

ATLANTA, Dec. 04, 2020 (GLOBE NEWSWIRE) — HD Supply Holdings, Inc. (NASDAQ: HDS), one of the largest industrial distributors in North America, today reported Net sales of $827.5 million for the third quarter of fiscal 2020 ended November 1, 2020, an increase of $2.3 million, or 0.3 percent, as compared to the third quarter of fiscal 2019.“I am very proud of the team as their focused execution continued to deliver improved results, in the face of turbulent end markets and organizational change,” stated Joe DeAngelo, Chairman and CEO of HD Supply. “It is a testament to their dedication to our customers and their commitment to safely delivering best-in-class service.”Gross profit decreased $3.7 million, or 1.1 percent, to $348.3 million for the third quarter of fiscal 2020, as compared to $352.0 million for the third quarter of fiscal...

Continue reading

Novartis announces first data from REACH3 trial showing Jakavi® (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD

Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms1Chronic graft-versus-host disease (GvHD) is a life-threatening complication of stem cell transplants and half of patients become steroid refractory/dependent2,3Findings from the study were presented at ASH 2020, and complement previously reported positive results for Jakavi in acute GvHD; data to be submitted to ex-U.S. health authorities4Basel, December 4, 2020 — Detailed results from the pivotal Phase III REACH3 study demonstrate Jakavi® (ruxolitinib) significantly improved outcomes across a range of efficacy measures in patients with steroid-refractory/dependent chronic graft-versus-host disease (GvHD) compared to best available therapy (BAT)1. The results of REACH3, the first successful, randomized Phase III...

Continue reading

Virbac : Declaration of the number of shares and voting rights 11/2020

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTSInformation on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers)Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.VIRBAC: Shaping the future of animal healthNYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRPCorporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.comWebsite: www.virbac.comAttachmentTotal_nb_of_voting_rights_and_shares 30_11_2020

Continue reading

Virbac : Déclaration d’actions et de droits de vote 11/2020

DECLARATION D’ACTIONS ET DE DROITS DE VOTEInformations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577Total net* = nombre total de droits de vote attachés au nombre total d’actions – actions privées de droit de voteVIRBAC: Façonnons l’avenir de la santé animaleNYSE Euronext – Compartiment A / Code ISIN : FR0000031577 / MNEMO : VIRPDirection financière : tél. 04 92 08 71 32 – e-mail : finances@virbac.comSite web : www.virbac.comPièce jointeDéclaration_actions_et_ droits_vote 30_11_2020

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.